Applicant, as named in the Orange Book
Acerus
Next listed expiry: Natesto on 17 Mar 2034. 1 products with live protection, 0 without.
Products with listed protection
| Drug | Earliest generic entry |
|---|---|
| Natesto NDA 205488 testosterone | 17 Mar 2034 patent, carve-out possible |
Recent events
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.